Compound Detail
CHEMBL982
NALMEFENE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL982 |
| Name | NALMEFENE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WJBLNOPPDWQMCH-MBPVOVBZSA-N |
| Therapeutic | ✓ Yes |
6
Targets
19
Activities
3
Assay Types
15
PK Parameters
20
Publications
12
Known Names
8
Indications
Molecular Properties
339.4
MW (Da)
2.51
ALogP
4
HBA
2
HBD
52.9
PSA (Ų)
0.81
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1995 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Alcoholism Substance-Related Disorders Dermatitis, Atopic Gambling Non-alcoholic Fatty Liver Disease Smoking Cessation Kidney Diseases Opioid-Related Disorders
ATC Classification
N07BB05
nalmefene
Level 1: NERVOUS SYSTEM
Level 2: OTHER NERVOUS SYSTEM DRUGS
Activity Summary
Ki 16 meas. best 10.08
Kd 2 meas. best 9.53
IC50 1 meas. best 6.11
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Kappa-type opioid receptor CHEMBL237 | Ki | 10.08 | 9.495 | 0.1 | 4 |
| Mu-type opioid receptor CHEMBL233 | Ki | 9.62 | 9.316 | 0.2 | 5 |
| Mu-type opioid receptor CHEMBL270 | Ki | 9.54 | 9.54 | 0.3 | 1 |
| Mu-type opioid receptor CHEMBL233 | Kd | 9.53 | 9.53 | 0.3 | 1 |
| Delta-type opioid receptor CHEMBL236 | Kd | 9.04 | 9.04 | 0.9 | 1 |
| Kappa-type opioid receptor CHEMBL3952 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| Delta-type opioid receptor CHEMBL269 | Ki | 8.47 | 8.47 | 3.4 | 1 |
| Delta-type opioid receptor CHEMBL236 | Ki | 8.03 | 7.8975 | 9.3 | 4 |
| Kappa-type opioid receptor CHEMBL237 | IC50 | 6.11 | 6.11 | 779.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 15.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 15.0 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.65 | - | Homo sapiens |
| Ke | 0.34 | nM | Homo sapiens |
| Ke | 1.02 | nM | Homo sapiens |
| Ke | 0.15 | nM | Homo sapiens |
| MRT | 9.1 | hr | Homo sapiens |
| T1/2 | 1.667 | hr | Rattus norvegicus |
| T1/2 | 0.3333 | hr | Mus musculus |
| T1/2 | 0.3333 | hr | Homo sapiens |
| T1/2 | 1.667 | hr | Rattus norvegicus |
| T1/2 | 0.3333 | hr | Mus musculus |
| T1/2 | 0.3333 | hr | Homo sapiens |
| T1/2 | 8.8 | hr | Homo sapiens |
| T1/2 | 11.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine